SCM
SGMO

Suffolk Capital Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Suffolk Capital Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-246,047
Closed -$1.43M – 150
2016
Q2 		$1.43M Sell
246,047
-30,232
-11% -$193K 0.18% 130
2016
Q1 		$1.67M Buy
276,279
+7,875
+3% +$47.3K 0.22% 125
2015
Q4 		$2.45M Buy
268,404
+17,519
+7% +$135K 0.31% 99
2015
Q3 		$1.42M Buy
250,885
+53,885
+27% +$444K 0.19% 124
2015
Q2 		$2.19M Buy
+197,000
New +$2.54M 0.26% 116

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Suffolk Capital Management's SGMO Position: Q3 2016 in Review

Suffolk Capital Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2016, closing a stake of 246,047 shares — an estimated $1.43M sold.

Suffolk Capital Management first reported a position in SGMO in Q2 2015 and held it in 5 quarters. The position peaked at $2.45M in Q4 2015. 124 funds tracked by Wall St. Rank hold SGMO as of Q3 2016.

  • Suffolk Capital Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2016 after selling out during the quarter.
  • Suffolk Capital Management sold 246,047 SANGAMO THERAPEUTICS INC shares in Q3 2016, an estimated $1.43M.
  • Suffolk Capital Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2015 and held it in 5 quarters.
  • Suffolk Capital Management's SANGAMO THERAPEUTICS INC position peaked at $2.45M in Q4 2015.
  • 124 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2016.

Based on Suffolk Capital Management's 13F filing for Q3 2016, filed 31 Oct 2016.